Absci Corporation.(ABSI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ABSI Absci Corporation.

Pre-Mkt 10-02 08:25:37 EDT

10.75

-0.02

-0.19%

盘前10.78

+0.03+0.28%

07:51 EDT

High11.27	Low10.55	Vol4.61M
Open10.80	D1 Closing10.77	Amplitude6.67%
Mkt Cap1.84B	Tradable Cap1.68B	Total Shares171.61M
T/O50.30M	T/O Rate2.94%	Tradable Shares156.49M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ABSI","market":"US","secType":"STK","nameCN":"Absci Corporation.","latestPrice":10.75,"timestamp":1790884800000,"preClose":10.77,"halted":0,"volume":4608584,"hourTrading":{"tag":"盘前","latestPrice":10.78,"preClose":10.75,"latestTime":"07:51 EDT","volume":4704,"amount":50791.576416,"timestamp":1790941894009,"change":0.03,"changeRate":0.002791,"amplitude":0.013563},"delay":0,"changeRate":-0.001857010213556135,"floatShares":156491374,"shares":171614010,"eps":-0.799886,"marketStatus":"Pre-Mkt","change":-0.02,"latestTime":"10-02 08:25:37 EDT","open":10.8,"high":11.27,"low":10.552,"amount":50299256.356336,"amplitude":0.066667,"askPrice":10.99,"askSize":74,"bidPrice":10.81,"bidSize":202,"shortable":3,"etf":0,"ttmEps":-0.799886,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790947800000},"marketStatusCode":1,"adr":0,"listingDate":1626926400000,"exchange":"NASDAQ","adjPreClose":10.75,"preHourTrading":{"tag":"盘前","latestPrice":10.78,"preClose":10.75,"latestTime":"07:51 EDT","volume":4704,"amount":50791.576416,"timestamp":1790941894009,"change":0.03,"changeRate":0.002791,"amplitude":0.013563},"postHourTrading":{"tag":"盘后","latestPrice":10.8171,"preClose":10.75,"latestTime":"19:58 EDT","volume":46814,"amount":503890.1048,"timestamp":1790899115744,"change":0.0671,"changeRate":0.006242,"amplitude":0.015321},"volumeRatio":1.2320175762841437,"impliedVol":0.9081,"impliedVolPercentile":0.196},"requestUrl":"/m/hq/s/ABSI/tweets","defaultTab":"tweets","newsList":[{"id":"1124840365","title":"Novartis Bets $7.8 Billion On MRNA Beyond Vaccines","url":"https://stock-news.laohu8.com/highlight/detail?id=1124840365","media":"Options & Short Sell","labels":[],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/1124840365?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:11","pubTimestamp":1790932272,"startTime":"0","endTime":"0","summary":"","market":"hk","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3059.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3059.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Novartis Bets $7.8 Billion On MRNA Beyond Vaccines","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIIB","AMGN","NVOH","ELIL","GERM","SBIO","XBI","NVS","NVO","TEMT","DNA","TEMC","ABT","NVOX","MRNY","REGN","RBOT","TEM","SNY","BMY","NVOC","BNTX","AZN","PFE","GILD","VERU","BEAM","RXRX","MRK","GSK","VIR","JNJ","MRNX","LLII","IDNA","ELIS","ABSI","LLY","GSKH","LLYX","CRSP","MRNA","NVAX","TXG","ABBV"],"isVideo":true,"video":{"duration":213,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3059.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3059.webp","audio_url":"https://static.tigerbbs.com/1c89c593761ab28aabf1a552eb3a775b.mp3","isAI":true},"gpt_icon":0},{"id":"1120137912","title":"From Exoskeletons to AI: ChronoScale's Billion-Dollar Pivot","url":"https://stock-news.laohu8.com/highlight/detail?id=1120137912","media":"Tech News Roundup","labels":[],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/1120137912?lang=en_us&edition=fundamental","pubTime":"2026-10-02 12:48","pubTimestamp":1790916487,"startTime":"0","endTime":"0","summary":"","market":"other","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3039.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3039.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"From Exoskeletons to AI: ChronoScale's Billion-Dollar Pivot","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHRN","TEM","TEMC","BEAM","TEMT","DNA","RBOT","TXG","CRSP","RXRX","ABSI"],"isVideo":true,"video":{"duration":176,"video_url":"https://news-video-sg.skytigris.cn/videos/remotion/3039/render_3039_1790915786173.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3039.webp","audio_url":"https://news-video-sg.skytigris.cn/videos/remotion/3039/tts/voiceover_6b46a617ba2088f4.mp3","isAI":true},"gpt_icon":0},{"id":"2672163847","title":"BTIG Keeps Their Buy Rating on AbSci (ABSI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672163847","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672163847?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:16","pubTimestamp":1790936201,"startTime":"0","endTime":"0","summary":"BTIG analyst Kambiz Yazdi maintained a Buy rating on AbSci yesterday and set a price target of $16.00. The company’s shares closed yesterday at $10...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/btig-keeps-their-buy-rating-on-absci-absi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/btig-keeps-their-buy-rating-on-absci-absi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672768058","title":"H.C. Wainwright Remains a Buy on AbSci (ABSI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672768058","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672768058?lang=en_us&edition=fundamental","pubTime":"2026-10-01 22:36","pubTimestamp":1790865415,"startTime":"0","endTime":"0","summary":"In a report released today, Swayampakula Ramakanth from H.C. Wainwright reiterated a Buy rating on AbSci, with a price target of $16.00. Ramakanth ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-absci-absi-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-absci-absi-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","BK4139","ABSI","BK4539","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672755431","title":"Analysts Offer Insights on Healthcare Companies: AbSci (ABSI), Summit Therapeutics (SMMT) and Sutro Biopharma (STRO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672755431","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672755431?lang=en_us&edition=fundamental","pubTime":"2026-10-01 17:20","pubTimestamp":1790846446,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on AbSci (ABSI), Summit Therapeutics (SMMT) and Sutro...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-absci-absi-summit-therapeutics-smmt-and-sutro-biopharma-stro-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-absci-absi-summit-therapeutics-smmt-and-sutro-biopharma-stro-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","XBI","BK4137","BK4585","BK4121","ABSI","BK4581","LU2488822045.USD","STRO","BK4588","HCSG","LU0029874061.USD","LU0128526141.USD","ARKG","BK4139","BK4539","SMMT","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669460682","title":"Absci Targets Mid-2027 Start for Phase 2 Storyline Trial of ABS-201 in Endometriosis Pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2669460682","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669460682?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:01","pubTimestamp":1790251264,"startTime":"0","endTime":"0","summary":"Absci targets mid-2027 start for Phase 2 STORYLINE trial of ABS-201 in endometriosis painAbsci outlined a planned Phase 2 STORYLINE trial for ABS-201, an AI-designed antibody for endometriosis-associa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDL9N0pHX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3D17.EUR","SG9999014005.SGD","IE00BN0W2V16.EUR","BK4539","ABSI","LU2210150020.SGD","SG9999014039.USD","LU2095319765.USD","BCDF","SG9999014013.SGD","LU2210149790.SGD","BK4112","IE00BN0W2T93.GBP","BK4585","BK4139","IE00BN0W2W23.USD","IE00BGHQF748.EUR","SG9999014021.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","ARKG","LU0314104364.USD","IE00BQXX3C00.GBP","IE00BQXX3F31.USD","BK4588","IE00B3QW5Z07.USD","NDAQ","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669460378","title":"Absci Announces Preliminary Details for Phase 2 Storyline™ Trial of AI-Designed Antibody Abs-201™ for Endometriosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2669460378","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669460378?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:00","pubTimestamp":1790251200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nTUA9NX8D3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","ARKG","ABSI","BK4139","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669348460","title":"Absci Corp - Phase 2 Trial Initiation Anticipated in Mid-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2669348460","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669348460?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:00","pubTimestamp":1790251200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nTUA9NX8D3:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ABSI","BK4539","ARKG","BK4121","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669855424","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2669855424","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669855424?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:10","pubTimestamp":1790165442,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Entera Bio (ENTX) and AbSci (ABSI) with bullish sent...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-348?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-348?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","ARKG","BK4121","BK4588","BK4139","LU0128526141.USD","XLV","LABU","LU0029874061.USD","ABSI","BK4581","HCSG","ENTX","BK4585","BK4137","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669910070","title":"Absci Price Target Maintained with a $11.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2669910070","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669910070?lang=en_us&edition=fundamental","pubTime":"2026-09-23 19:09","pubTimestamp":1790161740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ABSI/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","ARKG","BK4121","ABSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666530013","title":"Absci Initiated at Outperform by LifeSci Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2666530013","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666530013?lang=en_us&edition=fundamental","pubTime":"2026-09-10 05:05","pubTimestamp":1788987900,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ABSI/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","BK4121","ABSI","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666826655","title":"Absci initiated with an Outperform at LifeSci Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2666826655","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666826655?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:25","pubTimestamp":1788949513,"startTime":"0","endTime":"0","summary":"LifeSci Capital initiated coverage of Absci (ABSI) with an Outperform rating and $16 price target Published first on TheFly – the ultimate source f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/absci-initiated-with-an-outperform-at-lifesci-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/absci-initiated-with-an-outperform-at-lifesci-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABSI","BK4539","BK4121","BK4139","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665825327","title":"Absci price target raised to $15 from $13 at BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2665825327","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665825327?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:11","pubTimestamp":1788865868,"startTime":"0","endTime":"0","summary":"BTIG analyst Kambiz Yazdi raised the firm’s price target on Absci (ABSI) to $15 from $13 and keeps a Buy rating on the shares. ABS-201 offers a dif...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/absci-price-target-raised-to-15-from-13-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/absci-price-target-raised-to-15-from-13-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","BK4539","ABSI","BK4139","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322848","title":"Absci Price Target Raised to $16.00/Share from $13.00 by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322848","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322848?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:57","pubTimestamp":1788865020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ABSI/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ARKG","ABSI","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191932836","title":"Arm's Haas: AI Could Cure Cancer In Our Lifetime — If The Industry Can Build Enough Chips","url":"https://stock-news.laohu8.com/highlight/detail?id=1191932836","media":"AI Industry Frontlines","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191932836?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:40","pubTimestamp":1788860424,"startTime":"0","endTime":"0","summary":"","market":"fut","thumbnail":"https://static.tigerbbs.com/05500e88dd35c02215454aab95952bea","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/05500e88dd35c02215454aab95952bea"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Arm's Haas: AI Could Cure Cancer In Our Lifetime — If The Industry Can Build Enough Chips","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNA","ABSI","TXG","TEMT","CRSP","TEMC","BEAM","RXRX","TEM","RBOT"],"isVideo":true,"video":{"duration":73,"video_url":"https://news-video-sg.skytigris.cn/videos/remotion/1029/render_1029_1788859287938.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/1029.webp","audio_url":"https://news-video-sg.skytigris.cn/videos/remotion/1029/tts/voiceover_643e356a105563d1.mp3","isAI":true},"gpt_icon":0},{"id":"2664789544","title":"Can Absci’s (ABSI) Low-Frequency Hair Loss Therapy Redefine Its Long-Term Platform Potential?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664789544","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664789544?lang=en_us&edition=fundamental","pubTime":"2026-09-02 11:28","pubTimestamp":1788319737,"startTime":"0","endTime":"0","summary":"Earlier in 2026, Absci Corporation advanced clinical testing of an injection-based therapy for pattern hair loss, using just two to three doses over six months in a field that has seen little therapeutic change since the 1990s.\nThe company’s focus on a low-frequency dosing regimen for a long-underserved condition is drawing attention because regulatory filings are not expected until at least 2027, yet interest is already building around the potential treatment model.\nNext, we’ll explore how...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-absi/absci/news/can-abscis-absi-low-frequency-hair-loss-therapy-redefine-its","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-absi/absci/news/can-abscis-absi-low-frequency-hair-loss-therapy-redefine-its","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ARKG","ABSI","BK4139","BK4539","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661245946","title":"How Positive ABS-201 Phase 1 Data And Pipeline Momentum At Absci (ABSI) Has Changed Its Investment Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2661245946","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661245946?lang=en_us&edition=fundamental","pubTime":"2026-08-24 01:18","pubTimestamp":1787505483,"startTime":"0","endTime":"0","summary":"In August 2026, Absci Corporation reported positive interim Phase 1 data from its HEADLINETM trial of ABS-201 for pattern hair loss, indicating a favorable safety profile and an estimated half-life of at least 65 days, while also reaffirming plans to advance the program into endometriosis and a Phase 2 trial in 2026.\nThese early results suggest ABS-201 could offer infrequent dosing and a differentiated, non-sex-steroid approach in two large, under-served indications, alongside emerging...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-absi/absci/news/how-positive-abs-201-phase-1-data-and-pipeline-momentum-at-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-absi/absci/news/how-positive-abs-201-phase-1-data-and-pipeline-momentum-at-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","BK4121","ABSI","BK4539","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660480048","title":"AbSci (ABSI) Receives a Hold from Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2660480048","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660480048?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:58","pubTimestamp":1786971496,"startTime":"0","endTime":"0","summary":"In a report released today, Sean Laaman from Morgan Stanley maintained a Hold rating on AbSci, with a price target of $10.00. According to TipRanks...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/absci-absi-receives-a-hold-from-morgan-stanley-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/absci-absi-receives-a-hold-from-morgan-stanley-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","ARKG","ABSI","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659018860","title":"Analysts Are Bullish on Top Healthcare Stocks: Monopar Therapeutics Inc (MNPR), AbSci (ABSI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659018860","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659018860?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:30","pubTimestamp":1786566610,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Monopar Therapeutics Inc (MNPR) and AbSci (ABSI) wit...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-monopar-therapeutics-inc-mnpr-absci-absi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-monopar-therapeutics-inc-mnpr-absci-absi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABSI","BK4139","BK4539","BK4121","ARKG","MNPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659092299","title":"U.S. Stocks on the MOVE-Sutro Biopharma, Humacyte","url":"https://stock-news.laohu8.com/highlight/detail?id=2659092299","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659092299?lang=en_us&edition=fundamental","pubTime":"2026-08-13 00:17","pubTimestamp":1786551433,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Sutro Biopharma, HumacyteAugust 12 (Reuters)-Wall Street's main indexes rose on Wednesday, with the Nasdaq outperforming peers as upbeat earnings from AI infrastructure fi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL6N4490YK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA","SLN","LOCL","UFO","TPL","SMCI","CAVA","OFAL","DFTX","DPRE","NCMI","GAP","CRWV","EROC","TSHA","BIVI","NBIS","CHTR","ALT","O","EAT","STRO","SVV","CORD","SLNCF","FSLR","HRB","LAZR","HUMA","ANNX","TAN","UAMY","OPLN","EGGY","NBIX","CIEN","SMWB","NBIZ","TRMB","TECH","SMCL","ABSI","SMMT","SLXN","NTHI","PFGC","BETA","LUMA","WXM","LITE"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.absci.com;investors.absci.com","stockEarnings":[{"period":"1week","weight":0.0391},{"period":"1month","weight":0.2161},{"period":"3month","weight":-0.0749},{"period":"6month","weight":2.5131},{"period":"1year","weight":2.4345},{"period":"ytd","weight":2.0802}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":0.0029},{"period":"3month","weight":0.0258},{"period":"6month","weight":0.1649},{"period":"1year","weight":0.1429},{"period":"ytd","weight":0.1204}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. It has a collaboration with Memorial Sloan Kettering Cancer Center to discover novel therapeutics using generative AI; with AstraZeneca PLC for AI-driven drug discovery against an oncology target; and with Twist Bioscience Corporation to design a novel therapeutic using generative AI. The company was founded in 2011 and is headquartered in Vancouver, Washington.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.106318},{"month":2,"riseRate":0.6,"avgChangeRate":0.064917},{"month":3,"riseRate":0.4,"avgChangeRate":-0.085447},{"month":4,"riseRate":0.4,"avgChangeRate":0.03426},{"month":5,"riseRate":0.4,"avgChangeRate":0.033031},{"month":6,"riseRate":0.2,"avgChangeRate":0.025606},{"month":7,"riseRate":0.6,"avgChangeRate":0.127868},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.082694},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.063832},{"month":10,"riseRate":0.666667,"avgChangeRate":0.111183},{"month":11,"riseRate":0.2,"avgChangeRate":-0.134033},{"month":12,"riseRate":0.4,"avgChangeRate":0.218437}],"exchange":"NASDAQ","name":"Absci Corporation.","nameEN":"Absci Corporation."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Absci Corporation.(ABSI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Absci Corporation.(ABSI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Absci Corporation.,ABSI,Absci Corporation.股票,Absci Corporation.股票老虎,Absci Corporation.股票老虎国际,Absci Corporation.行情,Absci Corporation.股票行情,Absci Corporation.股价,Absci Corporation.股市,Absci Corporation.股票价格,Absci Corporation.股票交易,Absci Corporation.股票购买,Absci Corporation.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Absci Corporation.(ABSI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Absci Corporation.(ABSI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}